Rich trained in medicine at the University of Birmingham between 2007 and 2013, completing an additional intercalated degree in Clinical Science. On graduation, he completed the Academic Foundation Programme and then moved on to an NIHR Academic Clinical Fellowship in Haematology. Through this time, he developed both clinical and laboratory research interests. He is now undertaking a PhD under the supervision of Pip Nicolson and Samantha Montague in the platelet group at the University of Birmingham where he is studying mechanisms of platelet activation in PF4-mediated immunothrombotic disorders.
His clinical research has recently focused on the use of reversal agents in the treatment of patients who bleed whilst taking direct oral anticoagulants. He is leading the retrospective, UK-wide RAPIDO study that is investigating how reversal agents are used and the project has gathered data on over 2,000 patients.